A Brief Update on Technology Impacting Dermatology

In a discussion about the future of dermatology, Dr. Ross Lane Pearlman shares insights on the impact of technology, particularly artificial intelligence (AI) and machine learning. He outlines the importance of big data in dermatology, emphasizing the role of DataDerm as a critical initiative that enables automated data collection and analysis, yielding new research insights and facilitating clinical improvements. Dr. Pearlman explains foundational concepts such as AI, which simulates human thought, and machine learning, which derives predictive algorithms. He points out the potential benefits, including better workflow and new product developments, but also warns of challenges like the introduction of products that may hinder clinical practice. He highlights the significant interest from the industry in utilizing dermatology data for product development and market analysis, noting that valuable patient records can generate substantial revenue. Current uses of DataDerm include MIPS measure reporting, which helps clinicians improve patient care while navigating value-based payment systems. As machine learning continues to evolve, Dr. Pearlman addresses the limitations of current technologies, such as lesion identification applications, which lack sufficient accuracy for clinical use. He concludes with an optimistic view about the future, envisioning a reduction in mundane tasks through innovative tools while cautioning against biases and out-of-context uses in this rapidly changing landscape.